RecoverLINK Technology Pilot for HF Patients
Not Applicable
Completed
- Conditions
- Heart Failure
- Interventions
- Other: RecoverLINK technology
- Registration Number
- NCT02815085
- Lead Sponsor
- RecoverLINK
- Brief Summary
The primary objective is to examine feasibility of incorporating RecoverLINK into the standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii) workflow efficiency. As secondary objectives, the investigators will collect preliminary data to examine the association between patient engagement with the RecoverLINK app and (i) changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and 90-day time periods post-enrollment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
- Heart failure (HF) patients with a rapid follow up appointment scheduled at the Mount Sinai HF clinic
- English-speaking
- With either access to (i) an iOS smart device or (ii) wifi at-home
Exclusion Criteria
Patients meeting any of the following criteria:
- A heart transplant
- A mechanical circulatory support (MCS) device
- An altered mental status
- Serious co-morbidities (as identified by Mount Sinai team)
- Cognitive impairments (as identified by Mount Sinai team)
- Inability to use technology (as identified by Mount Sinai team)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description RecoverLINK technology RecoverLINK technology RecoverLINK is a two-part mHealth technology designed to supplement traditional care transitional programs for heart failure (HF) patients.
- Primary Outcome Measures
Name Time Method User engagement: # symptom surveys completed/30 days 30 days User satisfaction: Percent patients report "satisfied" via post-program survey 30 days Workflow efficiency: mean/median time to resolution of patient alerts 30 days
- Secondary Outcome Measures
Name Time Method Hospital admission 30, 60, 90 days Mean difference in pre/post SCHIFI score 30 days
Trial Locations
- Locations (1)
The Mount Sinai Hospital
🇺🇸New York, New York, United States